Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Ruggedness and Robustness Evaluation – V 2.0

Posted on By

Analytical Method Development: SOP for Ruggedness and Robustness Evaluation – V 2.0

Standard Operating Procedure for Evaluating Ruggedness and Robustness in Analytical Methods


Department Analytical Method Development
SOP No. SOP/AMD/201/2025
Supersedes SOP/AMD/201/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP describes the procedures for evaluating ruggedness and robustness of analytical methods developed within the Analytical Method Development department to ensure method reliability and performance under variable conditions, in alignment with

GMP and ICH Q2(R1) guidelines.

2. Scope

This SOP applies to all validated and development-stage analytical methods evaluated for ruggedness and robustness within the Analytical Method Development lab for both API and formulation projects.

3. Responsibilities

  • Analyst: Performs ruggedness and robustness studies and records observations.
  • Section In-Charge: Reviews results and ensures adherence to protocol.
  • QA Representative: Verifies data and approves reports for regulatory submission.
  • Department Head: Approves protocols and ensures overall compliance.
See also  Analytical Method Development: GC Method Development for Residual Solvents - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for implementation and periodic review of ruggedness and robustness evaluations.

5. Procedure

5.1 Ruggedness Evaluation

  1. Prepare the analytical method validation protocol including ruggedness parameters such as:
    • Different analysts
    • Different instruments
    • Different days
    • Different laboratories (if applicable)
  2. Analyze at least six replicates under each condition.
  3. Calculate system precision (RSD%) and compare across variables.
  4. Document findings in the Ruggedness Evaluation Report (Annexure-1).

5.2 Robustness Evaluation

  1. Identify critical parameters that could affect method performance such as:
    • Flow rate (±10%)
    • Mobile phase pH (±0.2 units)
    • Column temperature (±5°C)
    • Injection volume (±10%)
  2. Perform analysis with deliberate variations in each parameter.
  3. Compare retention time, resolution, peak shape, and recovery with standard conditions.
  4. Ensure RSD is within 2% and system suitability passes under each condition.
  5. Document results in the Robustness Evaluation Log (Annexure-2).
See also  Analytical Method Development: Heavy Metals Test Method Development - V 2.0

5.3 Data Handling and Documentation

  1. All chromatograms, system suitability reports, and data calculations shall be retained.
  2. Prepare summary reports indicating observed variability and justification of acceptance criteria.
  3. Obtain QA review before final approval.

5.4 Report Review and Approval

  1. The compiled report must be reviewed by a senior analyst and approved by the Department Head.
  2. Forward the final report to QA for archiving.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • RSD: Relative Standard Deviation
  • ICH: International Council for Harmonisation
  • HPLC: High Performance Liquid Chromatography

7. Documents

  1. Ruggedness Evaluation Report – Annexure-1
  2. Robustness Evaluation Log – Annexure-2
  3. System Suitability Checklist – Annexure-3

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • WHO TRS 996: Quality Assurance of Pharmaceuticals
  • GMP Guidelines for Analytical Method Validation
See also  Analytical Method Development: Drafting Analytical Specifications - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Rajesh Kumar Meena Pillai Sunita Reddy
Designation Sr. Analyst QA Reviewer AMD Head
Department AMD QA Analytical Method Development

11. Annexures

Annexure-1: Ruggedness Evaluation Report

Analyst Date Instrument RSD% Remarks
Anjali Singh 01/05/2025 HPLC-101 1.3 Accepted
Ramesh Pawar 02/05/2025 HPLC-103 1.5 Accepted

Annexure-2: Robustness Evaluation Log

Parameter Condition Result RSD% Conclusion
Flow Rate 0.9 mL/min RT 5.2 min 1.2 Pass
Flow Rate 1.1 mL/min RT 4.8 min 1.4 Pass

Annexure-3: System Suitability Checklist

Test ID Retention Time Resolution Theoretical Plates Status
SST-001 5.0 2.5 4500 Pass
SST-002 4.9 2.4 4300 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Complete SOP rewrite per ICH Q2(R1) Annual Review Sunita Reddy
15/03/2022 1.0 Initial Release New SOP Department Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Gel Manufacturing: SOP for Use of Color Coding in Gel Manufacturing Areas – V 2.0
Next Post: Elixir Department: SOP for Real-time Monitoring Sensors for Temperature – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version